 | • レポートコード：QY20ST-06333 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のパーキンソン病治療薬市場について種類別（カルビドパ/レボドパ、ドーパミン受容体アゴニスト、MAO阻害剤）、用途別（病院、オンライン、小売薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・パーキンソン病治療薬市場の概要 ・世界の主要地域別パーキンソン病治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のパーキンソン病治療薬市場規模2015-2026：種類別（カルビドパ/レボドパ、ドーパミン受容体アゴニスト、MAO阻害剤） ・世界のパーキンソン病治療薬市場規模2015-2026：用途別（病院、オンライン、小売薬局） ・パーキンソン病治療薬の北米市場規模2015-2020 ・パーキンソン病治療薬のヨーロッパ市場規模2015-2020 ・パーキンソン病治療薬の中国市場規模2015-2020 ・パーキンソン病治療薬の日本市場規模2015-2020 ・パーキンソン病治療薬の東南アジア市場規模2015-2020 ・パーキンソン病治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・パーキンソン病治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・パーキンソン病治療薬の市場動向・機会・課題 ・調査の結論 |
Researchers are working to develop new and improved therapies for people with Parkinson’s disease (PD). There have been many drugs that have been approved to treat Parkinson disease.
Market Analysis and Insights: Global Parkinsons disease Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Parkinsons disease Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Parkinsons disease Drug industry.
Based on our recent survey, we have several different scenarios about the Parkinsons disease Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Parkinsons disease Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Parkinsons disease Drug Scope and Market Size
The global Parkinsons disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinsons disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Parkinsons disease Drug market is segmented into
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Segment by Application, the Parkinsons disease Drug market is segmented into
Hospital
Online
Retail Pharmacies
The Parkinsons disease Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Parkinsons disease Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Parkinsons disease Drug Market Share Analysis
Parkinsons disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Parkinsons disease Drug business, the date to enter into the Parkinsons disease Drug market, Parkinsons disease Drug product introduction, recent developments, etc.
The major vendors covered:
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
1 Parkinsons disease Drug Market Overview
1.1 Parkinsons disease Drug Product Scope
1.2 Parkinsons disease Drug Segment by Type
1.2.1 Global Parkinsons disease Drug Sales by Type (2020-2026)
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Parkinsons disease Drug Segment by Application
1.3.1 Global Parkinsons disease Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Online
1.3.4 Retail Pharmacies
1.4 Parkinsons disease Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Parkinsons disease Drug Sales Growth Rate (2015-2026)
1.4.2 Global Parkinsons disease Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Parkinsons disease Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Parkinsons disease Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Parkinsons disease Drug Industry
1.5.1.1 Parkinsons disease Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Parkinsons disease Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Parkinsons disease Drug Players to Combat Covid-19 Impact
2 Parkinsons disease Drug Estimate and Forecast by Region
2.1 Global Parkinsons disease Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Parkinsons disease Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Parkinsons disease Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Parkinsons disease Drug Revenue Market Share by Region (2015-2020)
2.3 Global Parkinsons disease Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Parkinsons disease Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Parkinsons disease Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Parkinsons disease Drug Estimates and Projections (2015-2026)
2.4.2 Europe Parkinsons disease Drug Estimates and Projections (2015-2026)
2.4.3 China Parkinsons disease Drug Estimates and Projections (2015-2026)
2.4.4 Japan Parkinsons disease Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Parkinsons disease Drug Estimates and Projections (2015-2026)
2.4.6 India Parkinsons disease Drug Estimates and Projections (2015-2026)
3 Global Parkinsons disease Drug Competition Landscape by Players
3.1 Global Top Parkinsons disease Drug Players by Sales (2015-2020)
3.2 Global Top Parkinsons disease Drug Players by Revenue (2015-2020)
3.3 Global Parkinsons disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinsons disease Drug as of 2019)
3.4 Global Parkinsons disease Drug Average Price by Company (2015-2020)
3.5 Manufacturers Parkinsons disease Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Parkinsons disease Drug Players (Opinion Leaders)
4 Global Parkinsons disease Drug Market Size by Type
4.1 Global Parkinsons disease Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Parkinsons disease Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Parkinsons disease Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Parkinsons disease Drug Price by Type (2014-2020)
4.2 Global Parkinsons disease Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Parkinsons disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Parkinsons disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Parkinsons disease Drug Price Forecast by Type (2021-2026)
5 Global Parkinsons disease Drug Market Size by Application
5.1 Global Parkinsons disease Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Parkinsons disease Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Parkinsons disease Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Parkinsons disease Drug Price by Application (2015-2020)
5.2 Global Parkinsons disease Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Parkinsons disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Parkinsons disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Parkinsons disease Drug Price Forecast by Application (2021-2026)
3 North America Parkinsons disease Drug Market Facts & Figures
3.2 North America Parkinsons disease Drug Sales Market Share by Company (2015-2020)
3.3 North America Parkinsons disease Drug Sales Market Share by Type (2015-2020)
3.4 North America Parkinsons disease Drug Sales Market Share by Application (2015-2020)
4 Europe Parkinsons disease Drug Market Facts & Figures
4.2 Europe Parkinsons disease Drug Sales Market Share by Company (2015-2020)
4.3 Europe Parkinsons disease Drug Sales Market Share by Type (2015-2020)
4.4 Europe Parkinsons disease Drug Sales Market Share by Application (2015-2020)
5 China Parkinsons disease Drug Market Facts & Figures
5.2 China Parkinsons disease Drug Sales Market Share by Company (2015-2020)
5.3 China Parkinsons disease Drug Sales Market Share by Type (2015-2020)
5.4 China Parkinsons disease Drug Sales Market Share by Application (2015-2020)
6 Japan Parkinsons disease Drug Market Facts & Figures
6.2 Japan Parkinsons disease Drug Sales Market Share by Company (2015-2020)
6.3 Japan Parkinsons disease Drug Sales Market Share by Type (2015-2020)
6.4 Japan Parkinsons disease Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Parkinsons disease Drug Market Facts & Figures
7.2 Southeast Asia Parkinsons disease Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Parkinsons disease Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Parkinsons disease Drug Sales Market Share by Application (2015-2020)
8 India Parkinsons disease Drug Market Facts & Figures
8.2 India Parkinsons disease Drug Sales Market Share by Company (2015-2020)
8.3 India Parkinsons disease Drug Sales Market Share by Type (2015-2020)
8.4 India Parkinsons disease Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Parkinsons disease Drug Business
12.1 Teva
12.1.1 Teva Parkinsons disease Drug Corporation Information
12.1.2 Teva Parkinsons disease Drug Business Overview and Total Revenue
12.1.3 Teva Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teva Parkinsons disease Drug Products Offered
12.1.5 Teva Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Parkinsons disease Drug Corporation Information
12.2.2 Novartis AG Parkinsons disease Drug Business Overview and Total Revenue
12.2.3 Novartis AG Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis AG Parkinsons disease Drug Products Offered
12.2.5 Novartis AG Recent Development
12.3 GSK
12.3.1 GSK Parkinsons disease Drug Corporation Information
12.3.2 GSK Parkinsons disease Drug Business Overview and Total Revenue
12.3.3 GSK Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GSK Parkinsons disease Drug Products Offered
12.3.5 GSK Recent Development
12.4 AbbVie
12.4.1 AbbVie Parkinsons disease Drug Corporation Information
12.4.2 AbbVie Parkinsons disease Drug Business Overview and Total Revenue
12.4.3 AbbVie Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AbbVie Parkinsons disease Drug Products Offered
12.4.5 AbbVie Recent Development
12.5 Merck
12.5.1 Merck Parkinsons disease Drug Corporation Information
12.5.2 Merck Parkinsons disease Drug Business Overview and Total Revenue
12.5.3 Merck Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merck Parkinsons disease Drug Products Offered
12.5.5 Merck Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Parkinsons disease Drug Corporation Information
12.6.2 Boehringer Ingelheim Parkinsons disease Drug Business Overview and Total Revenue
12.6.3 Boehringer Ingelheim Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer Ingelheim Parkinsons disease Drug Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Impax Laboratories
12.7.1 Impax Laboratories Parkinsons disease Drug Corporation Information
12.7.2 Impax Laboratories Parkinsons disease Drug Business Overview and Total Revenue
12.7.3 Impax Laboratories Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Impax Laboratories Parkinsons disease Drug Products Offered
12.7.5 Impax Laboratories Recent Development
12.8 Lundbeck
12.8.1 Lundbeck Parkinsons disease Drug Corporation Information
12.8.2 Lundbeck Parkinsons disease Drug Business Overview and Total Revenue
12.8.3 Lundbeck Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lundbeck Parkinsons disease Drug Products Offered
12.8.5 Lundbeck Recent Development
12.9 Sun Pharma
12.9.1 Sun Pharma Parkinsons disease Drug Corporation Information
12.9.2 Sun Pharma Parkinsons disease Drug Business Overview and Total Revenue
12.9.3 Sun Pharma Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sun Pharma Parkinsons disease Drug Products Offered
12.9.5 Sun Pharma Recent Development
12.10 Wockhardt
12.10.1 Wockhardt Parkinsons disease Drug Corporation Information
12.10.2 Wockhardt Parkinsons disease Drug Business Overview and Total Revenue
12.10.3 Wockhardt Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Wockhardt Parkinsons disease Drug Products Offered
12.10.5 Wockhardt Recent Development
12.11 UCB
12.11.1 UCB Parkinsons disease Drug Corporation Information
12.11.2 UCB Parkinsons disease Drug Business Overview and Total Revenue
12.11.3 UCB Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 UCB Parkinsons disease Drug Products Offered
12.11.5 UCB Recent Development
12.12 Bausch Health
12.12.1 Bausch Health Parkinsons disease Drug Corporation Information
12.12.2 Bausch Health Parkinsons disease Drug Business Overview and Total Revenue
12.12.3 Bausch Health Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Bausch Health Parkinsons disease Drug Products Offered
12.12.5 Bausch Health Recent Development
12.13 Acadia
12.13.1 Acadia Parkinsons disease Drug Corporation Information
12.13.2 Acadia Parkinsons disease Drug Business Overview and Total Revenue
12.13.3 Acadia Parkinsons disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Acadia Parkinsons disease Drug Products Offered
12.13.5 Acadia Recent Development
13 Parkinsons disease Drug Manufacturing Cost Analysis
13.1 Parkinsons disease Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Parkinsons disease Drug
13.4 Parkinsons disease Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Parkinsons disease Drug Distributors List
14.3 Parkinsons disease Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Parkinsons disease Drug Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Parkinsons disease Drug Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Parkinsons disease Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Parkinsons disease Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Parkinsons disease Drug Players to Combat Covid-19 Impact
Table 8. Global Market Parkinsons disease Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Parkinsons disease Drug Sales (K Doses) by Region (2015-2020)
Table 10. Global Parkinsons disease Drug Sales Market Share by Region (2015-2020)
Table 11. Global Parkinsons disease Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Parkinsons disease Drug Revenue Share by Region (2015-2020)
Table 13. Global Parkinsons disease Drug Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Parkinsons disease Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Parkinsons disease Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Parkinsons disease Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Parkinsons disease Drug (K Doses) of Key Companies (2015-2020)
Table 18. Global Parkinsons disease Drug Sales Share by Company (2015-2020)
Table 19. Global Parkinsons disease Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Parkinsons disease Drug Revenue Share by Company (2015-2020)
Table 21. Global Parkinsons disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinsons disease Drug as of 2019)
Table 22. Global Parkinsons disease Drug Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Parkinsons disease Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Parkinsons disease Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Parkinsons disease Drug Players
Table 27. Global Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 28. Global Parkinsons disease Drug Sales Share by Type (2015-2020)
Table 29. Global Parkinsons disease Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Parkinsons disease Drug Price (K Doses) by Type (2015-2020)
Table 31. Global Parkinsons disease Drug Sales Share by Type (2021-2026)
Table 32. Global Parkinsons disease Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Parkinsons disease Drug Revenue Share by Type (2021-2026)
Table 34. Global Parkinsons disease Drug Price (K Doses) by Type (2021-2026)
Table 35. Global Parkinsons disease Drug Sales (K Doses) by Application (2015-2020)
Table 36. Global Parkinsons disease Drug Sales Share by Application (2015-2020)
Table 37. Global Parkinsons disease Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Parkinsons disease Drug Price (K Doses) by Application (2015-2020)
Table 39. Global Parkinsons disease Drug Sales (K Doses) by Application (2021-2026)
Table 40. Global Parkinsons disease Drug Sales Share by Application (2021-2026)
Table 41. Global Parkinsons disease Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Parkinsons disease Drug Revenue Share by Application (2021-2026)
Table 43. Global Parkinsons disease Drug Price (K Doses) by Application (2021-2026)
Table 44. United States Parkinsons disease Drug Sales (K Doses) by Company (2015-2020)
Table 45. United States Parkinsons disease Drug Sales Market Share by Company (2015-2020)
Table 46. United States Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 47. United States Parkinsons disease Drug Sales Market Share by Type (2015-2020)
Table 48. United States Parkinsons disease Drug Sales (K Doses) by Application (2015-2020)
Table 49. United States Parkinsons disease Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Parkinsons disease Drug Sales (K Doses) by Company (2015-2020)
Table 51. Europe Parkinsons disease Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 53. Europe Parkinsons disease Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Parkinsons disease Drug Sales (K Doses) by Application (2015-2020)
Table 55. Europe Parkinsons disease Drug Sales Market Share by Type (2015-2020)
Table 56. China Parkinsons disease Drug Sales (K Doses) by Company (2015-2020)
Table 57. China Parkinsons disease Drug Sales Market Share by Company (2015-2020)
Table 58. China Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 59. China Parkinsons disease Drug Sales Market Share by Type (2015-2020)
Table 60. China Parkinsons disease Drug Sales (K Doses) by Application (2015-2020)
Table 61. China Parkinsons disease Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Parkinsons disease Drug Sales (K Doses) by Company (2015-2020)
Table 63. Japan Parkinsons disease Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 65. Japan Parkinsons disease Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Parkinsons disease Drug Sales (K Doses) by Application (2015-2020)
Table 67. Japan Parkinsons disease Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Parkinsons disease Drug Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Parkinsons disease Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Parkinsons disease Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Parkinsons disease Drug Sales Market Share by Application (2015-2020)
Table 74. India Parkinsons disease Drug Sales (K Doses) by Company (2015-2020)
Table 75. India Parkinsons disease Drug Sales Market Share by Company (2015-2020)
Table 76. India Parkinsons disease Drug Sales (K Doses) by Type (2015-2020)
Table 77. India Parkinsons disease Drug Sales Market Share by Type (2015-2020)
Table 78. India Parkinsons disease Drug Sales (K Doses) by Application (2015-2020)
Table 79. India Parkinsons disease Drug Sales Market Share by Application (2015-2020)
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Teva Parkinsons disease Drug Product
Table 84. Teva Recent Development
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Novartis AG Parkinsons disease Drug Product
Table 89. Novartis AG Recent Development
Table 90. GSK Corporation Information
Table 91. GSK Description and Business Overview
Table 92. GSK Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. GSK Parkinsons disease Drug Product
Table 94. GSK Recent Development
Table 95. AbbVie Corporation Information
Table 96. AbbVie Description and Business Overview
Table 97. AbbVie Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. AbbVie Parkinsons disease Drug Product
Table 99. AbbVie Recent Development
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Merck Parkinsons disease Drug Product
Table 104. Merck Recent Development
Table 105. Boehringer Ingelheim Corporation Information
Table 106. Boehringer Ingelheim Description and Business Overview
Table 107. Boehringer Ingelheim Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Boehringer Ingelheim Parkinsons disease Drug Product
Table 109. Boehringer Ingelheim Recent Development
Table 110. Impax Laboratories Corporation Information
Table 111. Impax Laboratories Description and Business Overview
Table 112. Impax Laboratories Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Impax Laboratories Parkinsons disease Drug Product
Table 114. Impax Laboratories Recent Development
Table 115. Lundbeck Corporation Information
Table 116. Lundbeck Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Lundbeck Description and Business Overview
Table 118. Lundbeck Parkinsons disease Drug Product
Table 119. Lundbeck Recent Development
Table 120. Sun Pharma Corporation Information
Table 121. Sun Pharma Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Sun Pharma Description and Business Overview
Table 123. Sun Pharma Parkinsons disease Drug Product
Table 124. Sun Pharma Recent Development
Table 125. Wockhardt Corporation Information
Table 126. Wockhardt Description and Business Overview
Table 127. Wockhardt Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Wockhardt Parkinsons disease Drug Product
Table 129. Wockhardt Recent Development
Table 130. UCB Corporation Information
Table 131. UCB Description and Business Overview
Table 132. UCB Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. UCB Parkinsons disease Drug Product
Table 134. UCB Recent Development
Table 135. Bausch Health Corporation Information
Table 136. Bausch Health Description and Business Overview
Table 137. Bausch Health Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Bausch Health Parkinsons disease Drug Product
Table 139. Bausch Health Recent Development
Table . Acadia Corporation Information
Table . Acadia Description and Business Overview
Table . Acadia Parkinsons disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Acadia Parkinsons disease Drug Product
Table . Acadia Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Parkinsons disease Drug Distributors List
Table 148. Parkinsons disease Drug Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinsons disease Drug Product Picture
Figure 2. Global Parkinsons disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Parkinsons disease Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Online Examples
Figure 8. Retail Pharmacies Examples
Figure 9. Global Parkinsons disease Drug Sales (K Doses) Growth Rate (2015-2026)
Figure 10. Global Parkinsons disease Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Parkinsons disease Drug Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global Parkinsons disease Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Parkinsons disease Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Parkinsons disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Parkinsons disease Drug Sales (K Doses) Growth Rate (2015-2026)
Figure 16. Europe Parkinsons disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Parkinsons disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Parkinsons disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Parkinsons disease Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Parkinsons disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Parkinsons disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Parkinsons disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Parkinsons disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Parkinsons disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Parkinsons disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Parkinsons disease Drug Players Market Share by Revenue in Parkinsons disease Drug 2015 & 2019
Figure 27. Parkinsons disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Parkinsons disease Drug Revenue Share by Type (2015-2020)
Figure 29. Global Parkinsons disease Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Parkinsons disease Drug Revenue Share by Application (2015-2020)
Figure 31. Global Parkinsons disease Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Parkinsons disease Drug Sales Market Share by Type in 2019
Figure 33. United States Parkinsons disease Drug Sales Market Share by Type in 2019
Figure 34. Europe Parkinsons disease Drug Sales Market Share by Company in 2019
Figure 35. Europe Parkinsons disease Drug Sales Market Share by Type in 2019
Figure 36. Europe Parkinsons disease Drug Sales Market Share by Application in 2019
Figure 37. China Parkinsons disease Drug Sales Market Share by Company in 2019
Figure 38. China Parkinsons disease Drug Sales Market Share by Type in 2019
Figure 39. China Parkinsons disease Drug Sales Market Share by Application in 2019
Figure 40. Japan Parkinsons disease Drug Sales Market Share by Company in 2019
Figure 41. Japan Parkinsons disease Drug Sales Market Share by Type in 2019
Figure 42. Japan Parkinsons disease Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Parkinsons disease Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Parkinsons disease Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Parkinsons disease Drug Sales Market Share by Application in 2019
Figure 46. India Parkinsons disease Drug Sales Market Share by Company in 2019
Figure 47. India Parkinsons disease Drug Sales Market Share by Type in 2019
Figure 48. India Parkinsons disease Drug Sales Market Share by Application in 2019
Figure 49. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Impax Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Acadia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Parkinsons disease Drug
Figure 64. Manufacturing Process Analysis of Parkinsons disease Drug
Figure 65. Parkinsons disease Drug Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
予防的HIV薬の世界市場レポート2020 A recently published report by QY Research titled Global Prophylactic HIV Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…- ジドロゲステロン薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dydrogesterone Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dydrogesterone Drug marke…
- 抗エイズ薬の世界市場レポート2020 A recently published report by QY Research titled Global Anti-AIDs Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate dat…
- 末梢動脈疾患用薬剤溶出バルーンの世界市場レポート2020 A recently published report by QY Research titled Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also…
- 路上用薬物検査装置の世界市場レポート2020 A recently published report by QY Research titled Global Roadside Drug Testing Device Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provide…